Dolores Caballero

Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome

Jesús F. San Miguel, Júlia Almeida, Gema Mateo et al. · Blood · 2002 · 159 citations · Full text

Medicine, Hematology, Immunology +16

Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen et al. · Journal of Clinical Oncology · 2019 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Chronic but not acute graft‐versus‐host disease improves outcome in multiple myeloma patients after non‐myeloablative allogeneic transplantation

José Antonio Pérez‐Simón, Rodrigo Martino, Adrían Alegre et al. · British Journal of Haematology · 2003 · 103 citations

Medicine, Immunology, Oncology +15

Risk stratification for <scp>S</scp>plenic <scp>M</scp>arginal <scp>Z</scp>one <scp>L</scp>ymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

Carlos Montalbán, Víctor Abraira, Luca Arcaini et al. · British Journal of Haematology · 2012 · 91 citations · Full text

Medicine, Biostatistics, Oncology +13

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

Francisco Javier Peñalver, Víctor Jiménez‐Yuste, Manuel Almagro et al. · Annals of Hematology · 2006 · 82 citations

Life Sciences, Hematology, Immunology +10